NEPHROPLUSNSENephrocare Health Services LimitedLowNeutral
Announced Mon, 4 May · 15:00 IST

Nephrocare Health Services Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

NEPHROPLUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.2%1-day move
₹530.00
prior close
₹549.30
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0-0.1-0.2+2.2+0.8+3.8+2.5+8.0+10.8+16.5+24.5+27.2
Up moveDown movePending
AI summary

Nephrocare Health Services Limited (Nephroplus) has notified the exchanges about its Q4FY26 Results Conference Call scheduled for Wednesday, May 20, 2026 at 16:00 IST. The call will discuss the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. Key company executives including Chairman & Managing Director Mr. Vikram Vuppala, Co-Founder Mr. Kamal Shah, Group CEO Mr. Rohit Singh, and Group CFO Mr. Prashant Goenka will participate. The call is hosted by ICICI Securities. The company has clarified that no unpublished price sensitive information (UPSI) will be discussed, and discussions will be based solely on publicly available information.

Likely market impact

This is a standard regulatory disclosure informing investors of an upcoming earnings call. The explicit clarification that no UPSI will be discussed is a positive compliance signal, reducing speculation risk around the event.